Drug Database
Back to search

Netherlands· NL-cc0460f1d33f

Insulatard 100 internationale eenheden/ml suspensie voor injectie in injectieflacon

A insulin (human) product containing insuline isofaan, humaan, registered in Netherlands by Novo Nordisk A.S.. The same ATC class is registered in 11 of our 19 countries.

ATC A10AC01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedInsulatard 100 internationale eenhede…ATCA10AC01REGISTER NO.NL-cc0460f1d33fPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about insuline isofaan, humaanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Insulin (human) is registered in 11 of 19 countries.

Countries holding a registration under ATC A10AC01 (insulin (human)), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search insulin (human) products by name

Insulin (human) · ATC A10AC01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
INSULINE ISOFAAN, HUMAAN
Manufacturer
Novo Nordisk A.S.
Country
Netherlands (NL)
ATC code
A10AC01
ATC class
Insulin (human)
Defined daily dose
40 E, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/02/233

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

460 interactions on record for insulin (human).

Graded by severity as the source publishes them — 15 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check insulin (human) against other medicinesHow interaction checks work

Insulin (human) · interactions on record

460 records

  • 15 severe
  • 395 moderate
  • 50 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • PrednisoloneA07EA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under A10AC01

Insulin (human), as other registers publish it.

All insulin (human) products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e864479f-5f0b-4695-9b23-8ab6423cdee5
GET /v1/drugs/e864479f-5f0b-4695-9b23-8ab6423cdee5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/insulatard-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Insulin (Human)",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71504",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "FENOL",
    "GLYCEROL (E 422)",
    "METACRESOL",
    "NATRIUMHYDROXIDE (E 524)",
    "PROTAMINESULFAAT",
    "WATER VOOR INJECTIE",
    "ZINKDICHLORIDE 0-WATER",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "INSULINE ISOFAAN, HUMAAN"
  ],
  "leaflet_url": null,
  "authorised_at": "2002/10/07",
  "procedure_number": "EMEA/H/C/000441",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/02/233",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about insulin (human).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console